$3.35 0.05 (+1.52%)
11/25/2009 4:00 PM

DepoMed, Inc. (DEPO)

CAPS Rating: 2 out of 5

A specialty pharmaceutical company focused on the development and commercialization of differentiated products that address growing markets and are based on proprietary oral drug delivery technologies.

Featured Broker Partners